EXPERT INSIGHTS ON PLACENTA PREVIA: DIAGNOSIS AND MANAGEMENT TECHNIQUES

Placenta previa is a complex obstetric condition characterized by the abnormal implantation of the placenta in the lower uterine segment, either partially or completely covering the internal cervical os. This abnormal positioning can lead to significant maternal and fetal complications, primarily severe hemorrhage, especially during the third trimester of pregnancy and around the time of labor and delivery. Understanding placenta previa, its symptoms, diagnostic approaches, and treatment strategies is paramount for healthcare professionals to ensure optimal outcomes for both mother and child.

Understanding Placenta Previa: Definition and Types

Placenta previa is a condition where the placenta implants in the lower part of the uterus, potentially obstructing the baby’s exit route through the cervix. In a normal pregnancy, the placenta attaches to the upper part of the uterus, allowing for unobstructed passage of the fetus during vaginal delivery. When the placenta lies low in the uterus, it can either partially or completely cover the cervix, leading to challenges as the cervix begins to efface and dilate during labor.

The classification of placenta previa is critical for understanding its severity and guiding management decisions. Traditionally, placenta previa was categorized based on the degree to which the placenta covers the internal cervical os. While imaging has refined these definitions, the core concepts remain valuable:

• Complete (or Total) Placenta Previa: In this most severe form, the placenta completely covers the internal cervical os. This definitively blocks the birth canal, making vaginal delivery impossible without significant risk of hemorrhage.
• Partial Placenta Previa: The placenta partially covers the internal cervical os. While some portion of the os remains uncovered, a significant portion is still obstructed.
• Marginal Placenta Previa: The edge of the placenta is immediately adjacent to the internal cervical os but does not cover it. It lies within 2 cm of the os.
• Low-Lying Placenta: This term is often used when the placenta is located in the lower uterine segment, typically within 2 cm of the internal cervical os but not actually reaching it. While not technically a “previa,” it carries a higher risk of bleeding than a normally implanted placenta and often resolves as the uterus remodels.

It is important to note that the placenta can “migrate” or appear to move away from the cervix as the uterus grows and the lower uterine segment stretches during pregnancy. This phenomenon, known as trophotropism, means that a diagnosis of low-lying placenta or marginal previa in early to mid-pregnancy may resolve by term, while complete previa is less likely to resolve.

Incidence and Risk Factors: Placenta previa complicates approximately 1 in 200 pregnancies globally, though incidence varies by population and diagnostic criteria. Several factors increase a woman’s risk of developing placenta previa:

• Previous Cesarean Section: This is one of the strongest risk factors, with the risk increasing with each subsequent C-section due to scarring in the lower uterine segment.
• Previous Placenta Previa: A history of placenta previa significantly increases the risk in subsequent pregnancies.
• Multiparity: Women who have had multiple previous pregnancies are at higher risk.
• Advanced Maternal Age: Women over 35 years old have an increased risk.
• Multiple Gestations: Carrying twins, triplets, or more increases placental mass and the likelihood of a placenta covering the cervix.
• Uterine Scarring: Any prior uterine surgery, such as myomectomy (removal of fibroids), can contribute to abnormal placental implantation.
• Smoking: Maternal smoking is a modifiable risk factor.
• Cocaine Use: Illicit drug use, particularly cocaine, has been associated with an increased risk.
• Assisted Reproductive Technology (ART): Pregnancies conceived through ART may have a slightly higher risk due to altered uterine environment or implantation processes.

Symptoms and Signs of Placenta Previa

The cardinal symptom of placenta previa is painless vaginal bleeding in the second or third trimester of pregnancy. This bleeding can range from light spotting to profuse hemorrhage, and its characteristics are key to differentiating it from other causes of antepartum bleeding.

Typical Symptoms and Signs:

• Painless Vaginal Bleeding: This is the hallmark symptom.
  • Onset: The bleeding typically starts suddenly and without warning. It may occur during rest or activity.
  • Character: The blood is usually bright red, indicating fresh bleeding.
  • Amount: The bleeding can vary significantly. It may start as light spotting and then stop spontaneously, only to recur hours or days later, often heavier. In some cases, the initial bleed can be very heavy, leading to hypovolemic shock.
  • Recurrence: Bleeding episodes often recur, and subsequent episodes tend to be heavier as the lower uterine segment stretches and thins in late pregnancy, causing further separation of the placenta.
• Absence of Pain: Unlike placental abruption, where severe abdominal pain is common due to uterine contractions or retroplacental hemorrhage, placenta previa-related bleeding is typically painless. The uterus usually remains soft and relaxed to palpation, unless labor has commenced coincidentally.
• Absence of Uterine Tenderness: The uterus is generally non-tender, in contrast to the rigid, board-like abdomen often associated with placental abruption.
• Normal Fetal Heart Tones (initially): Unless the bleeding is severe enough to cause maternal hypovolemia or fetal compromise, fetal heart rate patterns are usually reassuring during initial bleeding episodes. However, with significant maternal blood loss, fetal tachycardia (compensatory) or even bradycardia (fetal distress) can occur.
• No Fetal Presentation Engagement: Due to the placenta occupying the lower uterine segment, the fetal head (or other presenting part) often remains high and unengaged in the pelvis.
• Shock (in severe cases): If the bleeding is heavy and prolonged, the mother may develop signs of hypovolemic shock, including pallor, tachycardia, hypotension, and dizziness.

Distinguishing from Other Causes of Antepartum Bleeding: It is crucial to differentiate placenta previa from other causes of vaginal bleeding in late pregnancy, such as:

• Placental Abruption: Characterized by painful vaginal bleeding, uterine tenderness, hypertonicity (rigid uterus), and often fetal distress.
• Vasa Previa: Where fetal blood vessels run unprotected across the internal cervical os. Bleeding is usually bright red, often coinciding with membrane rupture, and can rapidly lead to fetal exsanguination and distress.
• Cervical/Vaginal Lesions: Polyps, cervicitis, or carcinoma can cause bleeding, usually light and sporadic.
• Bloody Show: Light bleeding mixed with mucus that occurs as the cervix begins to efface and dilate in early labor.

Any vaginal bleeding in the second or third trimester warrants immediate medical evaluation to determine its cause and ensure maternal-fetal well-being.

Diagnosis of Placenta Previa

The diagnosis of placenta previa relies primarily on imaging studies, with ultrasonography being the gold standard. Once a woman presents with painless vaginal bleeding in the latter half of pregnancy, placenta previa should be high on the differential diagnosis.

Diagnostic Steps:

1. Clinical Suspicion:
   • Any woman presenting with painless vaginal bleeding after 20 weeks of gestation should be suspected of having placenta previa.
   • A thorough history, including risk factors, should be taken.
   • Crucially, a digital vaginal examination is contraindicated until placenta previa has been ruled out by ultrasound. Performing a digital exam when the placenta covers the cervical os can precipitate massive hemorrhage. If an examination is deemed necessary, it should be done carefully under “double setup” conditions in an operating room, where immediate C-section can be performed if severe bleeding occurs.
2. Ultrasonography:
   • Transabdominal Ultrasound: This is usually the initial diagnostic tool. It can identify the placental location relative to the internal cervical os. However, it may sometimes give a false impression of previa due to overdistended bladder or observer error.
   • Transvaginal Ultrasound (TVS): This is considered the most accurate and reliable method for diagnosing placenta previa. TVS provides a clearer, more precise image of the relationship between the placental edge and the internal cervical os. Numerous studies have confirmed its safety and superior accuracy compared to transabdominal ultrasound in placental localization. The transducer is placed just inside the vagina, close to the cervix, allowing for optimal visualization without needing to insert it into the cervical os. A diagnosis of placenta previa is typically confirmed if the placental edge is within 2 cm of, or covering, the internal cervical os.
   • Serial Ultrasonography: If a low-lying placenta or marginal previa is identified in the second trimester (e.g., at the anomaly scan around 18-22 weeks), serial ultrasounds are often performed in the third trimester (e.g., at 28-32 weeks, and again at 36 weeks if still present) to monitor for resolution. As the lower uterine segment stretches, the placenta may appear to “migrate” away from the os.
3. Magnetic Resonance Imaging (MRI):
   • While not a primary diagnostic tool for routine placenta previa, MRI can be used in complex cases or when ultrasound findings are unclear. It is particularly useful for assessing placental invasion disorders (e.g., placenta accreta spectrum disorders) when placenta previa is complicated by a history of previous uterine surgery, especially C-sections. MRI offers excellent soft tissue contrast and can visualize the extent of placental adherence to the uterine wall or invasion into adjacent structures.
4. Blood Tests:
   • While not diagnostic of placenta previa itself, blood tests are crucial for assessing the patient’s condition. These include:
     • Complete Blood Count (CBC) to check hemoglobin and hematocrit levels, indicating the extent of blood loss.
     • Blood type and Rh status to prepare for potential transfusions and administer Rh immunoglobulin if indicated.
     • Coagulation profile (PT, aPTT, fibrinogen) to assess clotting function, especially if significant bleeding or suspected coagulopathy.
     • Cross-matching for blood products.

Early and accurate diagnosis through ultrasound allows for appropriate management planning, which is vital for preventing serious complications.

Treatment of Placenta Previa

The management of placenta previa is highly individualized and depends on several factors: the gestational age, the amount and frequency of bleeding, the type of previa, the maternal and fetal condition, and the presence of associated complications such as placenta accreta spectrum. The overarching goals are to prolong the pregnancy to achieve fetal maturity while ensuring maternal stability and safety.

General Principles of Management:

• Hospitalization for Bleeding Episodes: Any significant bleeding warrants immediate hospitalization for close monitoring, assessment, and stabilization.
• Avoidance of Pelvic Examinations: Repeatedly emphasized, digital vaginal examinations are contraindicated until placenta previa is definitively ruled out or the woman is in an operating theater prepared for immediate C-section (double setup).
• Fetal Surveillance: Continuous monitoring of fetal well-being is essential through fetal heart rate monitoring, non-stress tests (NSTs), and biophysical profiles (BPPs).
• Maternal Stabilization: Maintaining hemodynamic stability of the mother is paramount, often requiring intravenous fluids and blood transfusions.

Treatment Approaches:

A. Expectant Management (for stable patients, remote from term): This approach aims to prolong the pregnancy to allow for fetal lung maturation and reduce the risks associated with prematurity. It is typically considered for women who are less than 37 weeks gestation, have a stable mother and fetus, and are experiencing minimal or no active bleeding.

1. Hospitalization vs. Outpatient Management:
   • Initially, hospitalization is usually recommended for at least 48-72 hours following a bleeding episode for observation.
   • If bleeding stops, the patient is hemodynamically stable, and home conditions allow for close monitoring and immediate access to medical care, some women can be managed as outpatients after a period of observation. However, inpatient management often provides higher safety.
   • Strict activity restrictions are advised, including pelvic rest (no intercourse, no tampons, no douching) and avoidance of strenuous activity.
2. Corticosteroids for Fetal Lung Maturity:
   • A course of antenatal corticosteroids (e.g., betamethasone or dexamethasone) is administered to women between 24 and 34 weeks gestation who are at risk of preterm delivery (due to bleeding or other indications). This helps accelerate fetal lung development and reduces the incidence and severity of respiratory distress syndrome (RDS) in preterm infants.
3. Blood Transfusion Readiness:
   • Mothers with placenta previa should have their blood type and screen readily available, and in cases of significant bleeding or anemia, cross-matched blood should be prepared for transfusion.
   • Iron supplementation may be prescribed for chronic blood loss leading to anemia.
4. Rh Immunoglobulin:
   • For Rh-negative mothers, Rh immunoglobulin (RhoGAM) should be administered after any bleeding episode to prevent Rh sensitization.
5. Tocolysis:
   • Tocolytic agents (drugs to stop uterine contractions) may be considered in cases where mild bleeding is associated with preterm labor contractions, to prolong pregnancy temporarily. However, they are generally contraindicated in active hemorrhage or significant fetal distress. Their use is controversial and often reserved for short-term delays (e.g., to allow for corticosteroid administration).
6. Timing of Delivery for Uncomplicated Previa:
   • For an asymptomatic, stable patient with persistent placenta previa (especially complete previa), an elective Cesarean section is typically scheduled between 36 weeks 0 days and 37 weeks 0 days gestation. This balances the risk of preterm delivery with the risk of spontaneous labor and potentially catastrophic hemorrhage.

B. Active Management (for severe bleeding, fetal distress, or near-term): Active management involves immediate delivery, usually via Cesarean section, when certain conditions arise.

1. Indications for Immediate Delivery:
   • Heavy, persistent, or uncontrollable vaginal bleeding: Regardless of gestational age, if maternal hemodynamic stability cannot be maintained.
   • Signs of maternal shock: Despite resuscitation efforts.
   • Fetal distress: Non-reassuring fetal heart rate patterns indicating compromise.
   • Labor onset with active bleeding: If labor progresses, the cervix dilates, leading to placental separation and hemorrhage.
   • Gestation at or beyond 37 weeks: If placenta previa persists, planned delivery is often indicated.
2. Cesarean Section:
   • Planned Delivery: For stable patients, a scheduled C-section is the safest mode of delivery. The surgical team must be prepared for potential complications, including massive hemorrhage.
   • Emergency Delivery: In cases of acute, severe hemorrhage or fetal distress, an emergency C-section is performed.
   • Surgical Considerations:
     • Anesthesia: Regional anesthesia (spinal or epidural) is often preferred if the patient is hemodynamically stable, but general anesthesia may be necessary in emergency situations or if severe hemorrhage is anticipated.
     • Incision: A classical (vertical) uterine incision may be necessary if the placenta is anterior and a lower segment transverse incision would cut through the placenta, leading to excessive bleeding. The goal is to avoid incising the placenta if possible.
     • Hemorrhage Control: Meticulous surgical technique, uterine massage, oxytocics, and sometimes uterine artery ligation, B-Lynch sutures, or even hysterectomy may be required in cases of intractable hemorrhage, especially if complicated by placenta accreta spectrum disorders.
     • Placenta Accreta Spectrum: Given the strong association between placenta previa (especially with previous C-sections) and placenta accreta, increta, or percreta, surgeons must be prepared for possible morbidly adherent placenta. This often involves a multidisciplinary team (obstetrician, anesthesiologist, interventional radiologist, urologist) and may necessitate planned hysterectomy or leaving the placenta in situ if the invasion is too deep.
3. Post-Delivery Care and Complications:
   • Maternal Hemorrhage: The primary concern. Close monitoring for postpartum hemorrhage is essential.
   • Blood Transfusion: May be required intra-operatively or post-operatively.
   • Infection: Increased risk due to surgery and potential blood loss.
   • Psychological Support: The experience can be stressful for the mother, requiring emotional support.
   • Fetal Complications: Prematurity-related issues (RDS, intraventricular hemorrhage, necrotizing enterocolitis) are the main fetal risks if delivered preterm.

In summary, placenta previa is a serious obstetric complication necessitating vigilant management. Early diagnosis via ultrasound, careful monitoring, and timely intervention—whether expectant management to prolong gestation or active management via Cesarean section for delivery—are critical to optimizing outcomes for both mother and baby. Given its potential for life-threatening hemorrhage, a high index of suspicion and a well-coordinated multidisciplinary approach are paramount.

References

1. American College of Obstetricians and Gynecologists (ACOG). (2018). Placenta Previa, Placenta Accreta, and Vasa Previa. ACOG Practice Bulletin, No. 189. Obstetrics & Gynecology, 131(1), e21-e39.
2. Cunningham, F. G., Leveno, K. J., Bloom, S. L., Dashe, J. S., Hoffman, B. L., Casey, B. M., & Spong, C. Y. (2018). Williams Obstetrics (25th ed.). McGraw-Hill Education.
3. Silver, R. M. (2018). Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. In R. K. Creasy, R. Resnik, J. Iams, C. Lockwood, T. Moore, & M. Greene (Eds.), Creasy and Resnik’s Maternal-Fetal Medicine: Principles and Practice (8th ed., pp. 583-601). Elsevier.
4. Royal College of Obstetricians and Gynaecologists (RCOG). (2011). Placenta Praevia and Placenta Accreta: Diagnosis and Management (Green-top Guideline No. 27a). RCOG.
5. Oppenheimer, L. W., Farine, D., Davies, G. A. L., Doran, S., Leduc, L., Popat, R., & Ruff, K. (2007). Diagnosing placenta previa: relationship between sonographic measurement of placental edge to internal os and perinatal outcome. Journal of Obstetrics and Gynaecology Canada, 29(1), 41-44.